LRRK2 and cancer: Furthermore, our study shows that LRRK2 high expression is associated with poor survival, more advanced clinical stage, and high pathological grade of OC patients, highlighting that cancers expressing high levels of LRRK2 are more resistant to treatment potentially through promotion of the HR pathway.